ArticleAmerican journal of respiratory and critical care medicine2020
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study.
Open access · hybridAbstract readMulticenter Study
In one paragraph
Article in American journal of respiratory and critical care medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 150 papers, 4 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
150citing papers in PubMed, 4 pooled it
23.8field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
150 citing papers in PubMed, 4 syntheses or guidelines pooled it, 237 citations in OpenAlex.
- Brazilian Thoracic Association recommendations for the management of lymphangioleiomyomatosis.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2025Guideline
- Interstitial lung disease independently associated with higher risk for COVID-19 severity and mortality: A meta-analysis of adjusted effect estimates.International immunopharmacology · 2022Pooled it
- Pre-existing interstitial lung disease in patients with coronavirus disease 2019: A meta-analysis.International immunopharmacology · 2021Pooled it
- Effect of comorbid pulmonary disease on the severity of COVID-19: A systematic review and meta-analysis.Respirology (Carlton, Vic.) · 2021Pooled it
- Interstitial Lung Disease in the United States: CDC Mortality Trends (1999-2024).Advances in respiratory medicine · 2026Article
- Disentangling Shared and Differential Genetic Architectures Between COVID-19 and Other Respiratory Disorders-A Genome-Wide Multi-Omics Framework.International journal of molecular sciences · 2026Article
- Vaccinations in patients with interstitial lung diseases: a narrative review.European respiratory review : an official journal of the European Respiratory Society · 2026Review
- Sex-specific trends in incidence and mortality of interstitial lung disease and pulmonary sarcoidosis in China compared with global estimates, 1990-2023: an analysis of GBD 2023.Journal of thoracic disease · 2026Article
- National and provincial burden of interstitial lung disease mortality in China, 2013-2021: a nationwide analysis of trends and underlying cause of death.Respiratory research · 2026Article
- Long-term radiologic trajectories and corticosteroid strategies in COVID-19 patients with pre-existing ILD: a 24-month cohort study.BMC pulmonary medicine · 2026Article
- Prevalence and outcomes of SARS-CoV-2 infection in ILD: Post-pandemic study in South Italy.Multidisciplinary respiratory medicine · 2026Article
- Computed tomography imaging features of major pulmonary and extrapulmonary complications of fibrotic lung diseases.Einstein (Sao Paulo, Brazil) · 2026Review
- Article
- Integrated Mendelian Randomization and Single-Cell RNA Sequencing Analyses Reveal Lactate Metabolism as a Key Pathway in COVID-19-Induced Pulmonary Fibrosis.Canadian respiratory journal · 2026Article
- Place of death among adults with interstitial lung disease in the United States, 1999-2023: a national population-based study.Annals of medicine and surgery (2012) · 2026Review
- Impact of COVID-19 Pandemic on Interstitial Lung Disease Healthcare Utilization and Outcomes: A Population Study in Alberta, Canada.Annals of the American Thoracic Society · 2025Article
- Clinical impacts of COVID-19 on severe exacerbation and mortality in interstitial lung disease: prognosis 30 days after infection.The Korean journal of internal medicine · 2025Article
- Association of vaccination status and immunosuppression with mortality of SARS-CoV-2 infection in patients with fibrotic interstitial lung disease.BMJ open respiratory research · 2025Article
- Article
- Hypersensitivity pneumonitis in Covid-19: mortality, risk factors, and clinical outcomes from a 30-case observational study.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2025Article
90 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
71 authors at 20 institutions in 6 countries.
Thomas M DrakeCentre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
Annemarie B DochertyCentre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
Ewen M HarrisonCentre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
Jennifer K QuintNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Huzaifa AdamaliBristol Interstitial Lung Disease Service, North Bristol NHS Trust and.
Sarah AgnewLiverpool Interstitial Lung Disease Service, Aintree site, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
Suresh BabuQueen Alexandra Hospital, Portsmouth, United Kingdom.
Christopher M BarberNorthern General Hospital, Sheffield, United Kingdom.
Shaney BarrattBristol Interstitial Lung Disease Service, North Bristol NHS Trust and.
Elisabeth BendstrupCentre for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
Stephen BianchiNorthern General Hospital, Sheffield, United Kingdom.
Diego Castillo VillegasInterstitial Lung Disease (ILD) Unit, Respiratory Medicine Department, Hospital of the Holy Cross and Saint Paul, Barcelona, Spain.
Nazia ChaudhuriILD Unit, Manchester University Hospital NHS Foundation Trust, Wythenshawe Hospital, Wythenshawe, United Kingdom.
Felix ChuaRoyal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
Robina CokerRespiratory Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
William ChangNottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Anjali CrawshawBirmingham Interstitial Lung Disease Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
Louise E CrowleyUniversity of Birmingham, Birmingham, United Kingdom.
Davinder DosanjhBirmingham Interstitial Lung Disease Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
Christine A FiddlerCambridge Interstitial Lung Disease Service, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.
Ian A ForrestDepartment of Respiratory Medicine, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Peter M GeorgeNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Michael A GibbonsSouth West Peninsula ILD Network, Royal Devon & Exeter Foundation NHS Trust, Exeter, United Kingdom.
Katherine GroomRespiratory Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Sarah HaneyNorthumbria Specialist Emergency Care Hospital, Northumbria Healthcare NHS Foundation Trust, Cramlington, United Kingdom.
Simon P HartRespiratory Research Group, Hull York Medical School, Castle Hill Hospital, Cottingham, United Kingdom.
Emily HeidenUniversity Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.
Michael HenryCork University Hospital, Cork, Ireland.
Ling-Pei HoOxford Interstitial Lung Disease Service, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Rachel K HoylesOxford Interstitial Lung Disease Service, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
John HutchinsonKing's Mill Hospital, Nottinghamshire, United Kingdom.
Killian HurleyDepartment of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
Mark JonesUniversity Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.
Steve JonesAction for Pulmonary Fibrosis, Stuart House, Peterborough, United Kingdom.
Maria KokosiRoyal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
Michael KreuterCenter for Interstitial and Rare Lung Diseases, Pneumology, Thoraxklinik, University of Heidelberg and German Center for Lung Research, Heidelberg, Germany.
Laura S MacKayNorthumbria Specialist Emergency Care Hospital, Northumbria Healthcare NHS Foundation Trust, Cramlington, United Kingdom.
Siva MahendranKingston Hospital NHS Foundation Trust, Surrey, United Kingdom.
George MargaritopoulosILD Unit, Manchester University Hospital NHS Foundation Trust, Wythenshawe Hospital, Wythenshawe, United Kingdom.
Maria Molina-MolinaILD Unit, Respiratory Department, University Hospital of Bellvitge, Institut d'Investigació Biomèdica de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
Philip L MolyneauxNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Aiden O'BrienUniversity Hospital Limerick, Limerick, Ireland.
Katherine O'ReillyDepartment of Respiratory Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.
Alice PackhamBirmingham Interstitial Lung Disease Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
Helen ParfreyCambridge Interstitial Lung Disease Service, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.
Venerino PolettiCentre for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
Joanna C PorterUCL Respiratory, University College London and ILD Service, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Elisabetta RenzoniRoyal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
Pilar Rivera-OrtegaILD Unit, Manchester University Hospital NHS Foundation Trust, Wythenshawe Hospital, Wythenshawe, United Kingdom.
Anne-Marie RussellNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Gauri SainiNottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
Lisa G SpencerLiverpool Interstitial Lung Disease Service, Aintree site, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
Giulia M StellaLaboratory of Biochemistry and Genetics, Pneumology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.
Helen StoneUniversity Hospital North Midlands NHS Trust, Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom.
Sharon SturneyRoyal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom.
David ThickettBirmingham Interstitial Lung Disease Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.ORCID 0000-0002-5456-6080
Muhunthan ThillaiCambridge Interstitial Lung Disease Service, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.
Tim WallisUniversity Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.
Katie WardNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Athol U WellsRoyal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
Alex WestGuys and St. Thomas' NHS Trust, London, United Kingdom.
Melissa WickremasingheImperial Healthcare NHS Trust, St. Mary's Hospital, The Bays, London, United Kingdom.
Felix WoodheadInstitute of Lung Health, Interstitial Lung Disease Unit, Glenfield Hospital, Leicester, United Kingdom.
Glenn HearsonNIHR Biomedical Research Centre, Respiratory Research Unit, University of Nottingham, Nottingham, United Kingdom.
Lucy HowardNIHR Biomedical Research Centre, Respiratory Research Unit, University of Nottingham, Nottingham, United Kingdom.
J Kenneth BaillieRoslin Institute, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0001-5258-793X
Peter J M OpenshawNational Heart and Lung Institute, Imperial College, London, United Kingdom.ORCID 0000-0002-7220-2555
Malcolm G SempleNIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom; and.
Iain StewartNIHR Biomedical Research Centre, Respiratory Research Unit, University of Nottingham, Nottingham, United Kingdom.
R Gisli JenkinsNottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
ISARIC4C Investigators
North Bristol NHS Trust · GBUniversity Hospitals Birmingham NHS Foundation Trust · GBImperial College Healthcare NHS Trust · GBNottingham University Hospitals NHS Trust · GBPapworth Hospital NHS Foundation Trust · GBRoyal Brompton & Harefield NHS Foundation Trust · GBUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Edinburgh · GBUniversity of Liverpool · GBUniversity of Manchester · GBUniversity of Nottingham · GBAarhus University Hospital · DKGuy's and St Thomas' NHS Foundation Trust · GBNorthern General Hospital · GBNorthumbria Healthcare NHS Foundation Trust · GBOxford University Hospitals NHS Trust · GBCastle Hill Hospital · GBCork University Hospital · IECystic Fibrosis Trust · GBGlenfield Hospital · GB
Funding
British Heart Foundation FS/18/13/33281Department of Health IS-HPU-1112-10117Department of Health RP-2016-07-012Medical Research Council G0701652Medical Research Council MC_PC_19025Medical Research Council MC_PC_19059Medical Research Council MR/S002782/1Medical Research Council MR/S019669/1Medical Research Council MR/S032304/1Medical Research Council MR/V033441/1Wellcome Trust 109965/Z/15/Z
Abstract
PubMed holds no abstract for this paper.
Indexed as
AgedAged, 80 and overComorbidityCOVID-19Disease ProgressionEuropeFemaleHospitalizationHumansLung Diseases, InterstitialMaleMiddle AgedRetrospective StudiesSARS-CoV-2Tomography, X-Ray ComputedCOVID-19idiopathic pulmonary fibrosisinterstitial lung diseaselung functionobesity
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.